Venmax Drugs achieved a significant turnaround in FY26, reporting a net profit of ₹0.25 Crores on ₹8.19 Crores in revenue, a 339.95% surge. Warrant conversions boosted share capital. However, quarterly profits dipped due to reduced 'othe...
Read More
Lupin Ltd announced a record fiscal year 2026, bringing in Rs 27,958 crores in revenue with strong EBITDA margins of 29.7%. The U.S. market was a key driver with 40% growth, and India's prescription segment also performed well. Looking a...
Read More
Senores Pharmaceuticals announced strong Q4 and full-year FY26 results, with net profit soaring 105% and 108% year-over-year. Growth was powered by increased revenue and strategic expansion in the U.S. market via acquisitions and joint v...
Read More
Innova Captab Ltd announced strong FY26 results, with revenue climbing 31% year-over-year to ₹1,630 crore and Profit After Tax (PAT) rising 10% to ₹140.9 crore. The company is undertaking significant capacity expansions, including a new...
Read More
Senores Pharmaceuticals reported a strong FY26 with net profit soaring 108% to ₹121.5 crore, and total income rising 62% to ₹664.0 crore. Strategic acquisitions and a US federal market joint venture are enhancing its market position and...
Read More
Global Health Limited announced its FY2026 results, reporting a consolidated profit after tax of ₹5,540.68 crore on revenue of ₹44,102.66 crore. The Board recommended a final dividend of ₹0.50 per share and signed agreements to expand wi...
Read More
Global Health (Medanta) reported strong Q4 FY26 results, with net profit hitting ₹141.65 crore on revenue of ₹1,195.79 crore, a 25.32% year-over-year increase. Full-year revenue rose 19.56% to ₹4,508.86 crore. New hospital expansions in...
Read More
Global Health Limited released its audited FY26 results. The company reported ₹4,410 crore in revenue and ₹5,540 crore in Profit After Tax (PAT). A final dividend of ₹0.50 per share was recommended. Global Health also plans significant h...
Read More
Akums Drugs and Pharmaceuticals Ltd reported strong FY26 results, with revenue growing 5.9% to ₹4,359 crore and adjusted profit after tax surging 27.3% to ₹276 crore. The company marked significant international progress with EU GMP cert...
Read More
Biocon Ltd reported Q4 FY26 results showing 10% year-over-year revenue growth, fueled by its biosimilar segment. The company also achieved a 23% EBITDA margin and reduced net debt to $1.1 billion. This signals a strategic shift towards v...
Read More
Natco Pharma announced it received a ₹4.92 crore demand notice from the National Pharmaceutical Pricing Authority (NPPA) concerning alleged drug overcharges between April and November 2023. The company has stated this notice will not mat...
Read More
Metropolis Healthcare announced that the audio recording of its Q4 FY26 earnings conference call is now available. The call, held on May 14, 2026, covered financial results for the quarter ending March 31, 2026. Investors can find manage...
Read More
Yatharth Hospital & Trauma Care Services Ltd secured overwhelming shareholder backing for creating security, such as charges or mortgages, through a postal ballot. The 99.99% approval signals strong support for management's future financ...
Read More
Akums Drugs & Pharmaceuticals is experiencing a temporary disruption at its Haridwar manufacturing facilities due to labour unrest in the SIDCUL industrial area. The company is working with authorities to resolve the issue quickly, but p...
Read More
Yatharth Hospital & Trauma Care Services Ltd shareholders have overwhelmingly approved a special resolution to create security over company assets. The vote, with 99.99% in favour, allows the company to mortgage or hypothecate its assets...
Read More
Star Imaging reported using ₹34.54 crore of its IPO funds by Q4 FY26 for working capital, loan repayment, and medical equipment. However, ₹15.13 crore remains unutilized, and the monitoring agency flagged potential commingling of funds.
Read More
Aurobindo Pharma Limited has set May 22, 2026, for its earnings call to present audited financial results for Q4 and the full fiscal year ending March 31, 2026. The call will offer investors and analysts insights into the company's perfo...
Read More
Dr. Agarwals Health Care Ltd will hold a board meeting on May 21, 2026, to approve its audited financial results for the fiscal year and quarter ending March 31, 2026. The company has also scheduled an analyst conference call for the sam...
Read More
Panchsheel Organics has clarified its status with BSE, confirming it is not classified as a "Large Corporate" and has no outstanding "Debt Securities." This aligns with SEBI's regulatory framework, providing clarity on its operational an...
Read More
Caplin Point Laboratories reported strong FY26 results, with consolidated net profit up 20.08% year-over-year to ₹649.73 Crores, and Q4 profit at ₹172.88 Crores. The company remains debt-free and declared a ₹4.00 per share interim divide...
Read More